Multiple approved drugs, such as copyright and Semaglutide, fall under the incretin mimetic group. Essentially , these therapies work by mimicking endogenous chemicals that control glucose levels and https://jayaiuio621431.affiliatblogger.com/93503564/these-medications-and-glp-1-receptor-agonists-getting-to-know-the-medications